Publications

5674 Results

SWOG 0802: A Randomized Phase II Trial of Weekly Topotecan With and Without AVE0005 (Aflibercept) in Patients with Platinum-treated Extensive Stage Small Cell Lung Cancer (E-SCLC)

Authors
J Allen;J Moon;S Gadgeel;K Kelly;PC Mack;H Saba;MK Mohamed;D Gandara
Journal / Conference
J Clin Oncol 30 (suppl; abstr 7005);American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), oral presentation;
Year
2012
Research Committee(s)
Lung
Study Number(s)
S0802

SWOG S0826: A Phase II Trial of SCH 727965 (NSC 747135) in Patients with Stage IV Melanoma

Authors
C Lao;J Moon;J Fruehauf;L Flaherty;M Bury;A Ribas;VK Sondak
Journal / Conference
J Clin Oncol 30 (suppl; abstr 8521); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), poster discussion;
Year
2012
Research Committee(s)
Melanoma
Study Number(s)
S0826

Randomized phase II study of docetaxel plus vandetanib (V+D) versus docetaxel followed by vandetanib (D --> V) in patients with persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma (OC): SWOG S0904

Authors
R Coleman;J Moon;A Sood;D Branham;J Delmore;A Bonebrake;G Anderson;D Alberts;M Markman
Journal / Conference
J Clin Oncol 30 (suppl; abstr 5015); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), poster discussion;
Year
2012
Research Committee(s)
Gynecologic
Study Number(s)
S0904

Phase II trial of RO4929097 Notch Gamma-Secretase Inhibitor in Metastatic Melanoma: SWOG S0933 (ClinicalTrials.gov Identifier: NCT01120275)

Authors
K Margolin;M Othus;T Gajewski;B Redman;T Chidiac;A Ribas;L Flaherty;V Sondak
Journal / Conference
J Clin Oncol 30 (suppl; abstr 8525); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
Year
2012
Research Committee(s)
Melanoma
Study Number(s)
S0933

SWOG 0941: A phase II study of Sorafenib and Erlotinib in patients (pts) with advanced gallbladder cancer or cholangiocarcinoma

Authors
A El-Khoueiry;C Rankin;S Iqbal;K Micetich;O Kayaleh;H Lenz;C Blanke
Journal / Conference
J Clin Oncol 30 (suppl; abstr 4113); American Society of Clinical Oncology 2012 Annual Mtg (June 1-5, 2012, Chicago, IL), poster presenetation;
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
S0941

Assessment of HER2 Gene Amplification in Adenocarcinomas of the Stomach or Gastroesophageal Junction in the INT-0116/SWOG9008 Clinical Trial

Authors
MA Gordon;H Gundacker;J Benedetti;J Macdonald;J Baranda;W Levin;N Wick;C Blanke;W Elatre;P Weng;J-Y Zhou;H Lenz;M Press
Journal / Conference
J Clin Oncol 30 (suppl; abstr 4010); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
Year
2012
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Intermittent (IAD) vs Continuous Androgen Deprivation (CAD) in Hormone Sensitive Metastatic Prostate Cancer (HSM1PC) Patients (pts): Results of S9346 (INT-0162) an International Phase III trial

Authors
M Hussain;C Tangen;C Higano;E Crawford;G Liu;G Wilding;S Prescott;A Akdas;E Small;N Dawson;B Donnelly;P Venner;U Vaishampayan;P Schellhammer;D Quinn;D Raghavan;N Vogelzang;IM Thompson
Journal / Conference
J Clin Oncol 30 (suppl; abstr 4); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), oral, plenary session;
Year
2012
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Preliminary quality of life outcomes for SWOG-9346: intermittent androgen deprivation in patients with hormone sensitive metastatic prostate cancer (HSM1PC), phase III

Authors
C Moinpour;DL Berry;B Ely;C Tangen;C Higano;J Picus;P Schellhammer;E Skinner;M Cher;I Thompson;M Hussain
Journal / Conference
Journal of Clinical Oncology 30 (suppl; abstr 4571); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), poster discussion;
Year
2012
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-9346

Chemotherapy plus Radiotherapy (CT-RT) vs. RT Alone for Patients with Anaplastic Oligodendroglioma: Long Term Results of the RTOG 9402 Phase III Study

Authors
J Cairncross;M Wang;E Shaw;R Jenkins;B Scheithauer;D Brachman;J Buckner;K Fink;L Souhami;N Laperriere;W Curran;M Mehta
Journal / Conference
J Clin Oncol 30 (suppl; abstr 2008b); American Society of Clinical Oncology 2012 Annual Meeting (June 1-5, 2012, Chicago, IL), oral;
Year
2012
Research Committee(s)
Brain

Chemoprevention of prostate cancer: an updated view [review]

Authors
EA Klein;IM Thompson
Journal / Conference
World Journal of Urology 30(2):189-194
Year
2012
Research Committee(s)
Prevention, Screening, and and Surveillance
PMID
PMID22238120
PMC
PMC n/a
Study Number(s)
S0000